Yisheng's PIKA Rabies Vaccine gets FDA Orphan Drug Designation

News   Jan 05, 2017 | Original Source From Yisheng Biopharma

 
Yisheng's PIKA Rabies Vaccine gets FDA Orphan Drug Designation
 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database

News

ACD/Labs technology enables automatic prediction of 1H and 13C spectra, using their industry-leading NMR prediction tools, for compounds already in the database and for new compounds as they are added in future.

READ MORE

Artificial Blood Vessels Mimic Rare Accelerated Aging Disease

News

Lab-grown blood vessels provide platform for studying premature aging syndrome and other rare diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE